MedTrace Logo

Acceptability, Barriers and Facilitators of a Communication Tool in Hospital Settings

NCT05986929 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2024-12-05

No results posted yet for this study

Summary

The presence of appropriate systems to promote good communication within the care team is one of the ten important characteristics identified for effective interdisciplinary work. However, the current communication systems at the Eastern Townships University Health and Social Services Centre of the Sherbrooke University Hospital (SUH), an hospital setting in Sherbrooke (Quebec, Canada), are numerous, scattered and difficult to identify quickly. The bedside magnetized posters were developed to address this issue. The use of this kind of tool should improve teamwork, communication, and patient care. As the bedside magnetized posters are now well established on the stroke and geriatric units at the SUH, it is essential to evaluate their acceptability by staff members. In addition, identifying the barriers and facilitators to their use will support the team for eventual deployment in other care environments at the SUH.

Conditions

  • Communication, Multidisciplinary

Interventions

OTHER

focus group

Two semi-structured group interviews, lasting 30-60 minutes, on facilitators and barriers to poster use by staff members (N=6-8).

OTHER

electronic survey

An electronic survey of 15 closed questions on the acceptability of the magnetic posters (N=100).

Sponsors & Collaborators

  • Fondation Vitae

    collaborator OTHER

  • Université de Sherbrooke

    lead OTHER

Principal Investigators

  • Marie-Helene Milot, PhD · Université de Sherbrooke

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-17
Primary Completion
2024-07-05
Completion
2024-07-05

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05986929 on ClinicalTrials.gov